The Prognostic Value of Estrogen and Progesterone Receptors in Female Breast Cancer. A Single Center Study

References

• Thorpe SM. Estrogen and progesterone receptor determina-tions in breast cancers. Technology, biology and clinical sig-nificance. Acta Oncol 1988; 27: 1–19.
   PubMed Web of Science ®Google Scholar
• Vollenvieder-Zerargui L, Barrelet L, Wong Y, Lemorchand-Bloaad T, Gomez F. The predictive value of estrogen and progesterone receptors concentrations on the clinical behavior of breast cancer in women Cancer 1986; 57: 1171–80.
   Google Scholar
• Mason BH, Holdaway IM, Mullins PR, Yee LH, Kay RG. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res 1983; 43: 2985–90.
   Google Scholar
• Mathiesen O, Carl J, Bonderup O, Panduro J. Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients Acta Oncol 1990; 29: 721–5.
   Google Scholar
• Thorpe SM, Poulsen HS, Pedersen KO, Rose C. Quality control of receptor analyses of breast cancer tissue in Den-mark. Acta Oncol 1988; 27: 621–5.
   PubMed Web of Science ®Google Scholar
• Papers from the Danish Breast Cancer Cooperative Group presented at the ten-year anniversary. Acta Oncol 1988; 27.
   Google Scholar
• Scharf RW, Tarloni H. Histological typing of breast tumours. Geneve: World Health Organisation, 1%8.
   Google Scholar
• Bloom HJ, Richardson WW. Histological grading and the prognosis in breast cancer. Br J Cancer 1957; 11: 3 59–77.
   Google Scholar
• Paulsen SM, Pedersen KO. Comparison of histo- and bio-chemical methods for estrogen and progesterone receptor analysis in primary human breast cancer. Eur J Cancer Clin Oncol 1985; 21: 1331–6.
   Google Scholar
• Sundergaard G, Pedersen KO, Paulsen SM. Estrogen receptor analysis in breast cancer: comparison of monoclonal immuno-histochemical and biochemical methods. Eur J Cancer Clin Oncol 1989 (Accepted for publication.)
   Google Scholar
• Horwitz KB, McGuire WL. Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 1978; 253: 2223–8.
   PubMed Web of Science ®Google Scholar
• EORTC Breast Cancer Co-operative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 1980; 16: 1513–5.
   PubMedGoogle Scholar
• Kaplan EL, Meier P. Non-parametric estimation from incom-plete observation. J Am Stat Assoc 1957; 53: 457-7 1.
   Google Scholar
• Cox DR. Regression models and life table. J R Stat Soc B 1972; 34: 187–220.
   Google Scholar
• Courdi A, Hery M, Chauvel P, Gioanni J, Namer M, Demard F. Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence of cut-off level. Br J Cancer 1988; 58: 88–90.
   Google Scholar
• Chevalier B, Heintzmann F, Mosseri V, et al. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Cancer 1988; 62: 2517–24.
   PubMed Web of Science ®Google Scholar
• Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS. Progesterone receptors as a prognostic factor in stage II breast cancer: N Eng J Med 1983; 309: 1343–7.
   Google Scholar
• Gelbfish GA, Davidson AL, Kopel S, et al. Relationship of estrogen and progesterone receptors to prognosis in breast cancer. Ann Surg 1988; 207: 75–9.
   Google Scholar
• Alexieva-Figusch J, Van Putten WL, Blankenstein MA, et al. The prognostic value and relationship of patient characteris-tics, estrogen and progestin receptors, and site of relapse in primary breast cancer. Cancer 1988; 61: 758–68.
   Google Scholar
• Rose C, Thorpe SM, Mouridsen HT, Andersen JA, Brincker H, Andersen KW. Antiestrogen treatment of postmenopausal women with primary high risk breast cancer. Breast Cancer Res Treat 1983; 3: 77–83.
   PubMed Web of Science ®Google Scholar
• Levitt SH. Is there a role for post-operative adjuvant irradia-tion in breast cancer? Int J Radik Oncol Biol Phys 1988; 14: 787–96.
   PubMed Web of Science ®Google Scholar
• Baum M. Nolvailex Adjuvant Trial Organization: Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer: analysis at six years. Lancet 1985; 1 : 836–40.
   Google Scholar
• Consensus Development Conference Report. Adjuvant chemotherapy for breast cancer. JAMA 1985; 254: 3461–3.
   PubMed Web of Science ®Google Scholar
• Valgussa P, Bonnadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978; 41: 1170–7.
   Google Scholar
• Fern M, Borg A, Johansson U, et al. Estrogen and proges-terone receptor analyses in more than 4000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Acta Oncol 1990; 29: 129–35.
   Google Scholar
• Saez S, Cheix F, Asselain B. Prognostic value of estrogen and progesterone receptors in primary breast cancer. Breast Can-cer Res Treat 1983; 3: 345–54.
   Google Scholar